Display options
Share it on

Indian J Clin Biochem. 2011 Apr;26(2):140-5. doi: 10.1007/s12291-010-0106-y. Epub 2011 Jan 13.

Involvement of Depressive Catecholamines as Thrombosis Risk/Inflammatory Markers in Non-Smoker, Non-Obese Congestive Heart Failure, Linked to Increased Epidermal Growth Factor-Receptor (EGF-R) Production.

Indian journal of clinical biochemistry : IJCB

Nadia M Hamdy, Lamiaa El-Wakeel, Salwa M Suwailem

PMID: 22468040 PMCID: PMC3107402 DOI: 10.1007/s12291-010-0106-y

Abstract

The EGF-R, also known as HER-1 or erbB-1 (EGF-R/HER-1/erbB-1), is a member of the human epithelial receptor tyrosine kinase family. sEGF-R is considered to play a role in cardiac (patho)physiology. We aimed to investigate whether soluble EGF-R is increased in congestive heart failure (CHF) patients and if related to disease severity. Soluble EGF-R, vitamin D, parathyroid hormone (PTH) was studied, and being evaluated in relation to Ca(2+), lipids, hsCRP, fibrinogen, serotonin, norepinepherine (NE). The study compared non-smoker, non-obese male CHF patients (n = 50) with age and gender-matched essential hypertension (HTN) patients (n = 20). Moreover, comparison with healthy control volunteers (n = 20) were employed. EGF-R/HER-1/erbB-1 was higher (P = 0.013) in 50 CHF male patients mean 12 ± 0.7 fmol/ml, than in 20 HTN, 9.25 ± 0.6 fmol/ml or in 20 controls, 6.25 ± 1 fmol/ml. Serum EGF-R levels correlated positively with hsCRP and NE, and were highest among CVD patients (n = 70) as well as negatively with vitamin D and HDL-C. EGF-R/HER-1/erbB-1 levels are increased in HTN and more in CHF patients. This study confirms a strong association between catecholamines as well as EGF-R/HER-1/erbB-1 levels with PTH and low vitamin D levels, being related to hyperlipidemia and inflammation (hsCRP and fibrinogen) in CVD. Moreover, contributing to the complex process of the inflammatory component of atherosclerosis in hypertensive patients that leads eventually to CHF.

Keywords: 25-hydroxy vitamin D; CHF; Catecholamines; Depression; EGF-R/HER-1/erbB-1; Fibrinogen

References

  1. J Chromatogr B Biomed Sci Appl. 2000 Sep 15;746(2):297-304 - PubMed
  2. Cardiovasc Res. 2006 Feb 15;69(3):666-76 - PubMed
  3. J Clin Pathol. 1969 Mar;22(2):158-61 - PubMed
  4. Toxicol Appl Pharmacol. 2008 May 1;228(3):315-25 - PubMed
  5. Curr Opin Nephrol Hypertens. 2007 Mar;16(2):134-42 - PubMed
  6. Circulation. 2000 Oct 3;102(14):1634-8 - PubMed
  7. Clin Chem. 1972 Jun;18(6):499-502 - PubMed
  8. Clin Chem. 1983 Jun;29(6):1075-80 - PubMed
  9. JAMA. 2001 May 16;285(19):2486-97 - PubMed
  10. BMC Med Genet. 2008 Aug 12;9:77 - PubMed
  11. Am J Prev Med. 2002 Jul;23(1):51-61 - PubMed
  12. Cleve Clin J Med. 2009 Apr;76 Suppl 1:S2-7 - PubMed
  13. Hypertension. 2008 Aug;52(2):301-7 - PubMed
  14. BMC Med Genet. 2008 Jul 30;9:74 - PubMed
  15. Clin Chem. 1973 Dec;19(12):1350-6 - PubMed
  16. J Am Coll Cardiol. 2008 Apr 8;51(14):1349-56 - PubMed
  17. Circulation. 2010 Feb 23;121(7):e46-e215 - PubMed
  18. Eur J Heart Fail. 2007 Feb;9(2):173-7 - PubMed
  19. J Am Coll Cardiol. 2006 Oct 17;48(8):1527-37 - PubMed
  20. Am J Clin Pathol. 1972 Oct;58(4):376-82 - PubMed
  21. Heart. 2003 Sep;89(9):993-7 - PubMed
  22. Br J Nutr. 2003 May;89(5):552-72 - PubMed
  23. J Lipid Res. 1970 Nov;11(6):583-95 - PubMed

Publication Types